Please be advised that the site will be down for maintenance on Sunday, September 1, 2024, from 08:00 to 18:00, and again on Monday, September 2, 2024, from 08:00 to 09:00. We apologize for any inconvenience this may cause.
dc.contributor.author | Rossouw, Theresa M.![]() |
|
dc.date.accessioned | 2016-05-11T13:03:46Z | |
dc.date.available | 2016-05-11T13:03:46Z | |
dc.date.issued | 2016-01 | |
dc.description.abstract | Antiretroviral treatment (ART) has dramatically changed the course of (HIV) infection, allowing for control of the virus in the peripheral circulation, significant reconstitution of the immune system and achievement of near-normal life expectancy. Similar to other antimicrobial agents, the efficacy of ART is, however, curtailed by the development of drug resistance. Resistance can either be transmitted from an infected partner/mother or acquired through inadequate drug pressure, usually caused by suboptimal adherence, treatment interruptions, improper treatment regimens, impaired drug absorption or drug interactions. Of these, adherence problems are by far the most common cause and remain a significant obstacle to achieving lifelong virological control. | en_ZA |
dc.description.department | Family Medicine | en_ZA |
dc.description.department | Immunology | en_ZA |
dc.description.librarian | am2016 | en_ZA |
dc.description.uri | http://www.medicalchronicle.co.za | en_ZA |
dc.identifier.citation | Rossouw, TM 2016, 'ARV options in drug resistance', Medical Chronicle, Dec/Jan 2016, pp. 24. | en_ZA |
dc.identifier.uri | http://hdl.handle.net/2263/52570 | |
dc.language.iso | en | en_ZA |
dc.publisher | New Media Publishing | en_ZA |
dc.rights | New Media Publishing (Pty) Ltd. | en_ZA |
dc.subject | Drug resistance | en_ZA |
dc.subject | Virological control | en_ZA |
dc.subject | Infection | en_ZA |
dc.subject | Antiretroviral treatment (ART) | en_ZA |
dc.subject | Human immunodeficiency virus (HIV) | en_ZA |
dc.subject.other | Health sciences article SDG-03 | |
dc.subject.other | SDG-03: Good health and well-being | |
dc.title | ARV options in drug resistance | en_ZA |
dc.type | Article | en_ZA |